Literature DB >> 27614702

Inhibition of chikungunya virus by picolinate that targets viral capsid protein.

Rajesh Sharma1, Benazir Fatma1, Amrita Saha2, Sailesh Bajpai3, Srinivas Sistla3, Paban Kumar Dash2, Manmohan Parida2, Pravindra Kumar1, Shailly Tomar4.   

Abstract

The protein-protein interactions (PPIs) of the transmembrane glycoprotein E2 with the hydrophobic pocket on the surface of capsid protein (CP) plays a critical role in alphavirus life cycle. Dioxane based derivatives targeting PPIs have been reported to possess antiviral activity against Sindbis Virus (SINV), the prototype alphavirus. In this study, the binding of picolinic acid (PCA) to the conserved hydrophobic pocket of capsid protein was analyzed by molecular docking, isothermal titration calorimetry (ITC), surface plasmon resonance (SPR) and fluorescence spectroscopy. The binding constant KD obtained for PCA was 2.1×10(-7)M. Additionally, PCA significantly inhibited CHIKV replication in infected Vero cells, decreasing viral mRNA and viral load as assessed by qRT-PCR and plaque reduction assay, respectively. This study is suggestive of the potential of pyridine ring compounds as antivirals against alphaviruses and may serve as the basis for the development of PCA based drugs against alphaviral diseases.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiviral; Capsid protein; Chikungunya virus; Picolinic acid; Protein-protein interactions; Pyridine ring, Surface Plasmon resonance; Quantitative real-time RT-PCR

Mesh:

Substances:

Year:  2016        PMID: 27614702     DOI: 10.1016/j.virol.2016.08.029

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

Review 1.  Vaccine and Therapeutic Options To Control Chikungunya Virus.

Authors:  Ann M Powers
Journal:  Clin Microbiol Rev       Date:  2017-12-13       Impact factor: 26.132

Review 2.  A review on structural genomics approach applied for drug discovery against three vector-borne viral diseases: Dengue, Chikungunya and Zika.

Authors:  Shobana Sundar; Shanmughavel Piramanayagam; Jeyakumar Natarajan
Journal:  Virus Genes       Date:  2022-04-08       Impact factor: 2.332

3.  Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach.

Authors:  Ziyad Tariq Muhseen; Alaa R Hameed; Halah M H Al-Hasani; Muhammad Tahir Ul Qamar; Guanglin Li
Journal:  J Mol Liq       Date:  2020-10-07       Impact factor: 6.165

Review 4.  The Interplay of Viral and Host Factors in Chikungunya Virus Infection: Targets for Antiviral Strategies.

Authors:  Kai Zhi Wong; Justin Jang Hann Chu
Journal:  Viruses       Date:  2018-05-30       Impact factor: 5.048

5.  The effect of amantadine on an ion channel protein from Chikungunya virus.

Authors:  Debajit Dey; Shumaila Iqbal Siddiqui; Prabhudutta Mamidi; Sukanya Ghosh; Chandra Shekhar Kumar; Soma Chattopadhyay; Subhendu Ghosh; Manidipa Banerjee
Journal:  PLoS Negl Trop Dis       Date:  2019-07-24

6.  Multi-core-shell composite SnO2NPs@ZIF-8: potential antiviral agent and effective photocatalyst for waste-water treatment.

Authors:  Ramesh Chandra; Vedita Singh; Shailly Tomar; Mala Nath
Journal:  Environ Sci Pollut Res Int       Date:  2019-06-13       Impact factor: 4.223

Review 7.  Small Molecule Inhibitors Targeting Chikungunya Virus.

Authors:  Nicole Haese; John Powers; Daniel N Streblow
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

Review 8.  Current Strategies for Inhibition of Chikungunya Infection.

Authors:  Bharat Bhusan Subudhi; Soma Chattopadhyay; Priyadarsee Mishra; Abhishek Kumar
Journal:  Viruses       Date:  2018-05-03       Impact factor: 5.048

9.  Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach.

Authors:  Shweta Choudhary; Yashpal S Malik; Shailly Tomar
Journal:  Front Immunol       Date:  2020-07-10       Impact factor: 7.561

Review 10.  A compendium of small molecule direct-acting and host-targeting inhibitors as therapies against alphaviruses.

Authors:  Kuan-Chieh Ching; Lisa F P Ng; Christina L L Chai
Journal:  J Antimicrob Chemother       Date:  2017-11-01       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.